The controversy over the association between statins use and progression of age-related macular degeneration: A mini review

Clinical Ophthalmology

Volumn 4, Issue 1, 2010, Pages 865-869

  Peponis, Vasileios ^a   Chalkiadakis, Spyridon E ^a   Bonovas, Stefanos ^b,c   Sitaras, Nikolaos M ^b  

^a Athens Eye Hospital   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Hellenic Centre for Disease Control and Prevention   (Greece)

Author keywords

Age related macular degeneration (AMD); Blindness; Controversy; Statin use

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; SIMVASTATIN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BLINDNESS; BLURRED VISION; BRUCH MEMBRANE; CHOROID CAPILLARY LAYER; CHOROID VASCULARIZATION; CLINICAL TRIAL; DRUSEN; HUMAN; HYDROSTATIC PRESSURE; PIGMENT EPITHELIUM; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK REDUCTION; VASCULAR RESISTANCE; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 77956115761     PISSN: 11775467     EISSN: 11775483     Source Type: Book Series    
DOI: None     Document Type: Review

References (41)

1. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003;290:2057-2060
2. Fine SL, Maguire MG. It is not time to abandon radiotherapy for neovascular age-related macular degeneration. Arch Ophthalmol. 2001;119:275-276
3. Fine SL, Berger JW, Maguire MG, Ho AC. Age-related macular degeneration. N Engl J Med. 2000;342:483-492
4. Friedman E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 2000;130: 658-663
5. Friedman E. A hemodynamic model of the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 1997;124:677-682
6. Friedman E, Smith TR, Kuwabara T. Senile choroidal vascular patterns and drusen. Arch Ophthalmol. 1963;69:220-230
7. Malek G, Li CM, Guidry C, Medeiros NE, Curcio CA. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol. 2003;162:413-425
8. Dithmar S, Sharara NA, Curcio CA, et al. Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane. Arch Ophthalmol. 2001;119:1643-1649
9. Green WR, Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology. 1993;100:1519-1535
10. Friedman E, Ivry M, Ebert E, Glynn R, Gragoudas E, Seddon J. Increased scleral rigidity and age-related macular degeneration. Ophthalmology. 1989;96:104-108
11. Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol. 2000; 118:351-358
12. van Leeuwen R, Ikram MK, Vingerling JR, Witteman JC, Hofman A, de Jong PT. Blood pressure, atherosclerosis, and the incidence of agerelated maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2003;44:3771-3777
13. Bird AC, Marshall J. Retinal pigment epithelial detachments in the elderly. Trans Ophthalmol Soc U K 1986;105:674-682
14. Kureishi Y, Luo Z, Shiojima I, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med. 2000;6:1004-1010
15. Simons M. Molecular multitasking: statins lead to more arteries, less plaque. Nat Med. 2000;6:965-966
16. Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001;286:64-70
17. Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol. 1985;223:69-76
18. Martini E, Scorolli L, Burgagni MS, Fessehaie S. Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile. Annali Di Ottalmologia e Clinica Oculistica. 1991;117:1121-1126
19. Della V, Scorolli L, Meduri R. Retinal effects of simvastatin in patients affected by age related macular degeneration. Annali Di Ottalmologia e Clinica Oculistica. 2000;126:89-95
20. Chuo JY, Wiens M, Etminan M, Maberley DA. Use of lipid-lowering agents for the prevention of age-related macular degeneration: a meta-analysis of observational studies. Ophthalmic Epidemiol. 2007; 14:367-374
21. Hall NF, Gale CR, Syddall H, Phillips DI, Martyn CN. Risk of macular degeneration in users of statins: cross sectional study. BMJ. 2001;323: 375-376
22. McCarty CA, Mukesh BN, Guymer RH, Baird PN, Taylor HR. Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med J Aust. 2001;175:340.
23. Delcourt C, Michel F, Colvez A, Lacroux A, Delage M, Vernet MH. Associations of cardiovascular disease and its risk factors with agerelated macular degeneration: the POLA study. Ophthalmic Epidemiol. 2001;8:237-249
24. Chavis PS, Castillo IG, Schwartz SG, et al. Risk factors for age-related macular degeneration. Invest Ophthalmol Vis Sci. 2003:5038.
25. Wilson H, Bhatt HRF, Schwartz DM, et al. Statin therapy is associated with decreased odds of developing neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2003:1804.
26. Wilson HL, Schwartz DM, Bhatt HR, McCulloch CE, Duncan JL. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol. 2004;137:615-624
27. Klein R, Klein BE, Tomany SC, Danforth LG, Cruickshanks KJ. Relation of statin use to the 5-year incidence and progression of agerelated maculopathy. Arch Ophthalmol. 2003;121:1151-1155
28. Klein R, Knudtson MD, Klein BE. Statin use and the five-year incidence and progression of age-related macular degeneration. Am J Ophthalmol. 2007;144:1-6
29. van Leeuwen R, Vingerling JR, Hofman A, de Jong PT, Stricker BH. Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement. BMJ. 2003;326:255-256
30. McGwin G Jr, Owsley C, Curcio CA, Crain RJ. The association between statin use and age related maculopathy. Br J Ophthalmol. 2003;87:1121-1125
31. McGwin G Jr, Xie A, Owsley C. The use of cholesterol-lowering medications and age-related macular degeneration. Ophthalmology. 2005;112:488-494
32. Smeeth L, Cook C, Chakravarthy U, Hubbard R, Fletcher AE. A case control study of age related macular degeneration and use of statins. Br J Ophthalmol. 2005;89:1171-1175
33. Friedman E, Rigas IK, Makar M. The relationship of statin use to the development of age-related macular degeneration. IOVS. 2005;46:199.
34. Tan JS, Mitchell P, Rochtchina E, Wang JJ. Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study. Am J Ophthalmol. 2007;143:685-687
35. McGwin G Jr, Modjarrad K, Hall TA, Xie A, Owsley C. 3-hydroxy- 3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study. Arch Ophthalmol. 2006;124:33-37
36. Drobek-Slowik M, Karczewicz D, Safranow K, Jakubowska K, Chlubek D. Use of statins as a form of protection against age-related macular degeneration (AMD). Klin Oczna. 2008;110:50-54
37. Etminan M, Brophy JM, Maberley D. Use of statins and angiotensin converting enzyme inhibitors (ACE-Is) and the risk of age-related macular degeneration: nested case-control study. Curr Drug Saf. 2008;3: 24-26
38. Guymer RH, Dimitrov PN, Varsamidis M, et al. Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS). Clin Interv Aging. 2008;3:581-593
39. Kaiserman N, Vinker S, Kaiserman I. Statins do not decrease the risk for wet age-related macular degeneration. Curr Eye Res. 2009;34: 304-310
40. Maguire MG, Ying GS, McCannel CA, Liu C, Dai Y. Statin Use and the Incidence of Advanced Age-Related Macular Degeneration in the Complications of Age-Related Macular Degeneration Prevention Trial. Ophthalmology. 2009.
41. Fong DS, Contreras R. Recent statin use and 1-year incidence of exudative age-related macular degeneration. Am J Ophthalmol. 149: 955-958